Evidence map›Paper›PMID 31710647›Full record

ArticlePloS one2019

Post-treatment Lyme disease symptoms score: Developing a new tool for research.

Siu P Turk, Keith Lumbard, Kelly Liepshutz, Carla Williams, Linden Hu, Kenneth Dardick, Gary P Wormser, Joshua Norville, Carol Scavarda, Donna McKenna and 2 more

Registry-linked trialAbstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02446626 (Xenodiagnosis After Antibiotic Treatment for Lyme Disease - Phase II Study), which is not on this map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02446626 nacompletednot on this map

Xenodiagnosis After Antibiotic Treatment for Lyme Disease - Phase II Study

TypeinterventionalSponsorNational Institute of Allergy and Infectious Diseases (NIAID)Ran2015 to 2022Enrolled72ConditionsLyme DiseaseArmsSkin biopsy, Blood draw, Xenodiagnosis
3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Xenodiagnosis to Search for Borrelia burgdorferi After Antibiotic Treatment of Lyme Disease: A Prospective Cohort Study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
    Trial
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Persistent Symptoms After Treatment of Lyme Disease.Infectious disease clinics of North America · 2022
    Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Siu P TurkLaboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Keith LumbardClinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
Kelly LiepshutzLeidos Biomedical Research, Inc., Clinical Services Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
Carla WilliamsLeidos Biomedical Research, Inc., Clinical Services Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
Linden HuTufts University School of Medicine, Boston, Massachusetts, United States of America.
Kenneth DardickMansfield Family Practice, Storrs, Connecticut, United States of America.ORCID 0000-0002-1315-6106
Gary P WormserInfectious Diseases, New York Medical College, Valhalla, New York, United States of America.
Joshua NorvilleTufts University School of Medicine, Boston, Massachusetts, United States of America.
Carol ScavardaInfectious Diseases, New York Medical College, Valhalla, New York, United States of America.
Donna McKennaInfectious Diseases, New York Medical College, Valhalla, New York, United States of America.
Dean FollmannBiostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Adriana MarquesLaboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.ORCID 0000-0002-5403-4551

Funding

Searching for Persistence in Lyme DiseaseU01AI109656 · NIAID · TUFTS UNIVERSITY BOSTON · PI HU, LINDEN T · 2014 to 2018
$4.0M
CCR NIH HHS HHSN261200800001CNCI NIH HHS HHSN261200800001ENIAID NIH HHS U01 AI109656
6 · The paper itself

Abstract

Some patients have residual non-specific symptoms after therapy for Lyme disease, referred to as post-treatment Lyme disease symptoms or syndrome, depending on whether there is functional impairment. A standardized test battery was used to characterize a diverse group of Lyme disease patients with and without residual symptoms. There was a strong correlation between sleep disturbance and certain other symptoms such as fatigue, pain, anxiety, and cognitive complaints. Results were subjected to a Logistic Regression model using the Neuro-QoL Fatigue t-score together with Short Form-36 Physical Functioning scale and Mental Health component scores; and to a Decision Tree model using only the QoL Fatigue t-score. The Logistic Regression model had an accuracy of 97% and Decision Tree model had an accuracy of 93%, when compared with clinical categorization. The Logistic Regression and Decision Tree models were then applied to a separate cohort. Both models performed with high sensitivity (90%), but moderate specificity (62%). The overall accuracy was 74%. Agreement between 2 time points, separated by a mean of 4 months, was 89% using the Decision Tree model and 87% with the Logistic Regression model. These models are simple and can help to quantitate the level of symptom severity in post-treatment Lyme disease symptoms. More research is needed to increase the specificity of the models, exploring additional approaches that could potentially strengthen an operational definition for post-treatment Lyme disease symptoms. Evaluation of how sleep disturbance, fatigue, pain and cognitive complains interrelate can potentially lead to new interventions that will improve the overall health of these patients.

Indexed as

Biomedical ResearchCohort StudiesDecision TreesFemaleHumansLogistic ModelsMaleMiddle AgedPost-Lyme Disease SyndromeReproducibility of ResultsSurveys and Questionnaires

Identifiers

PMID31710647
PMCPMC6844481

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.